CURRENT CLINICAL TRIALS FOR THE MPDs Content Managers: Ruben A. Mesa, MD; Srdan Verstovsek, MD; Ayalew Tefferi, MD
· Trials for Myelofibrosis · Trials for Polcythemia Vera · Trials for Essential Thrombocythemia · Trials for other MPDs · International MPD Centers · National MPD Centers
MPD CENTERS PARTICIPATING:
1. Trials for Myelofibrosis
Type of MPD
Drug Name
Drug Class
How do you take it?
Company
Background Info/Eligibility (click for more info)
Sites/Contact Info
MF
Bortezomib
Proteosome Inhibitor
IV
Millenium
Bortezomib Trial
Mayo Clinic Rochester, MN mesa.ruben@mayo.edu
Mayo Clinic Jacksonville, FL rivera.candido@mayo.edu
MD Anderson Cancer Center sverstov@mdanderson.org
Azacytadine
Hypo-methylating agent
SQ
Pharmion
Azacytadine Trial
Mayo Clinic Rochester mesa.ruben@mayo.edu
CC-4047 +/- prednisone
Immuno-modulatory
Pills
Celgene
Pomalidomide I Trial
Many sites in the USA and International (Hit Link)
INCB018424
JAK2 Inhibitor
Incyte
Mayo Clinic Rochester (Now Open) pardanani.animesh @mayo.edu
MD Anderson Cancer Center (Now open) sverstov@mdanderson.org
CEP-701
JAK2/ FLT3 Inhibitor
Cephalon
MD Anderson Cancer Center
XL019
Exelixis
MD Anderson Cancer Center (Now open)
sverstov@mdanderson.org
Mayo Clinic Rochester (Opening soon)
pardanani.animesh@mayo.edu
Sunitinib
Anti-angiogenic
NCI Sponsored
GX15-070MS
Pro-apoptotic
GeminX
MF: Myelofibrosis, Primary myelofibrosis (post ET/PV myelofibrosis) IV: Intravenous SQ: Subcutaneous
[ Back To Top ]
PV
Pegasys
Pegylated interferon
Roche
CMML SM
HES
Imatinib
Tyrosine Kinase Inhibitor
Novartis
Cladribine + Cytarabine
Purine Nucleoside Analog
2-CDA/ARA-C
SM
RAD001
MTOR inhibitor
HES: Hypereosinophilic syndrome CMML; Chronic myelomonocytic leukemia SM: Systemic mast cell disease
For Questions Contact: Ian Sweet | Webmaster: Digital Attic, LLC. www.MPDInfo.org is a resource of the CMPD Education Foundation.